ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma.

Scott F Huntington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.